Methods, compositions, and compounds for allosteric modulation o

Details Methods, compositions, and compounds for allosteric modulation o Methods, compositions, and compounds for allosteric modulation o

1991-08-13

1993-08-03

Tsang, Cecilia

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514169, 514172, 514177, 514178, 514179, 514180, 514181, 514182, 540 94, 540 95, 540 96, 540 97, 540 98, 540 99, 540106, 540107, 540108, 540109, 540110, 540111, 540112, A61K 3158, A61K 3156, C07J 4300, C07J 4100

Patent

active

052329178

ABSTRACT:
Method, compositions, and compounds for modulating brain excitability to alleviate stress, anxiety, insomnia and seizure activity using certain steroid derivatives that act at a newly identified site on the gamma-aminobutyric acid receptor-chloride ionophore (GR) complex.

REFERENCES:
patent: 4213978 (1980-07-01), Bodor et al.
Majewska et al, Science 233, p. 1004 (1986).
Gyermek et al, J. Med. Chem. 11, p. 117 (1968).
Laidlaw, Lancet, 1235-1237 (1956).
Asid et al, J. Amer. Med. Soc. 145, p. 715 (1951).
Backstrom, T. et al., Acta Obstet. Gynecol. Scand. Suppl., 130:19-24, 1985.
Backstrom, T. et al., J. Psychosom. Obstet. Gynaecol., 2:8-20, 1983.
Belelli, D. et al. Eur. J. Pharmacol, 166:325-329, 1989.
Blumstein, L. K. et al., Pharmac. Biochem. Behav., 18:37-40, 1983.
Bodor, N., Drugs of the Future, 6(3):165-182 (1981).
Bruhwyler, J., Eur. J. Pharmacol., 187:547-549, 1990.
Bruhwyler, J., et al., Pharmacol. Biochem. Behav., 36:57-61, 1990.
Bundgaard, H., Design of Prodrugs (H. Bundgaard, ed.), Elsevier, New York (1985).
Christmas, A. J., et al., Neuropharmacology, 9:17-29, 1970.
Crawley, J. N., et al., Pharmac. Biochem. Behav., 13:167-170, 1980.
Crawley, J. N. , Pharmac. Biochem. Behav., 15:695-699, 1981.
Crawley, J. N., et al., Neuropharmacology, 23:531-537, 1984.
Crawley, J. N. et al., Brain Res. Bull., 8:609-612, 1982.
Crawley, J. N., et al, Brain Res., 398:382-385, 1986.
Dalton, K., Premenstrual Syndrome and Progesterone Therapy, 2nd edition, Chicago: Chicago yearbook, 1984.
Davies, C. et al., Neurosci. Lett., 46:347-351, 1984.
Dennerstein, et al., British Medical Journal, 290:1617-1621, 1985.
File, S. E., J. Neurosci. Meth., 2:219-238, 1980.
Gee, K. W., et al., Mol. Pharmacol., 30:218-225, 1986.
Gee, K. W., et al., Drugs In Central Nervous System Disorders, pp. 123-147, D. C. Horwell, ed., 1985.
Gee, K. W., et al., European Journal of Pharmacology, 136:419-423, 1987.
Geller, L., et al., Psychopharmacologia, 3:374-385, 1962.
Harrison, N. L., et al., J. Pharmacol. Exp. Ther., 241:346-353, 1987.
Hughes, R. N., et al., Psychopharmacologia, 42:289-292, 1975.
Lambert, J., et al., Trends Pharmacol. Sci., 8:224-227, 1987.
Lawrence, L. J., et al., Biochem. Biophys. Res. Comm., 123:1130-1137, 1984.
Lister, R., Pharmacol. Ther., 46:321-340, 1990.
Lloyd, K. G., et al., Psychopharmacology: The Third Generation of Progress, pp. 183-195, H. Y. Meltzer, ed., Raven Press, N.Y., 1987.
Maddocks, S., et al., Am. J. Obstet. Gynecol., 154:573-581, 1986.
Maksay, G., et al. J. Neurochem., 44:480-486, 1985.
Marker, R. E., et al., J. Am. Chem. Soc. 59, 616-618, 1937.
Marrian, G. F., et al, Biochem., 40:376-380, 1946.
Mattson, R. H., Advances in epileptology: XVth Epilepsy Internatinoal Symposium, Raven Press, New York, 279-282, 1984.
Notari, R. E., Methods in Enzymology, 112:309-323, 1985.
Pfaff, D. W., et al., Science, 219:808-814, 1983.
Purdy, R. H., et al., J. Med. Chem., 33:1572-1581, 1990.
Rosciszewska, et al., J. Neurol. Neurosurg. Psych., 49:47-51, 1986.
Sansone, M., Psychopharmacology, 66:109-110, 1979.
Squires, R. F., et al, Mol. Pharmacol., 23:326-336, 1983.
Swinyard & Woodhead, in Antiepileptic Drugs, pp. 111-126 (Raven Press, New York), 1982.
Treit, D., Neurosci. Biobehav. Rev., 9:203-222, 1985.
Vogel, R. A. et al., J. Pharmacol. Exp. Thera., 212:153-161, 1980.
Vogel, J., et al., Psychopharmacologia, 21:1-7, 1971.
Wood, et al., J. Pharmacol. Exp. Thera., 231:572-576, 1984.
Worms, et al., J. Pharmacol. Exp. Thera., 220:660-671, 1982.

Affiliated with

Also associated with

Rating

Methods, compositions, and compounds for allosteric modulation o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods, compositions, and compounds for allosteric modulation o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods, compositions, and compounds for allosteric modulation o will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2270436